Stockreport

Nurix Therapeutics GAAP EPS of -$0.67 beats by $0.05, revenue of $12.6M misses by $2.04M [Seeking Alpha]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF Cash, cash equivalents and marketable securities was $457.5 million as of August 31, 2024, compared to $452.5 million as of May 31, 2024. More on Nurix Therapeutics [Read more]